The Leishmaniasis Treatment Market Is Estimated To Increase At A CAGR Of 4.23 Percent During The Forecast Period
Leishmaniasis is a parasitic disease caused by Leishmania. The Leishmania parasite is a single-celled protozoan that is spread through the bite of an infected female phlebotomine sand fly . The bite of infected female phlebotomine sandflies transmits Leishmania to humans. There are over 20 species of Leishmania reported. Furthermore, Leishmania parasites are transmitted by approximately 90 species of sandflies. Visceral Leishmaniasis, Cutaneous Leishmaniasis, and mucocutaneous Leishmaniasis are the three types of leishmaniasis. From 2019 to 2026, the Leishmaniasis Treatment Market is expected to increase at a CAGR of 4.23 percent, from USD 40.5 million in 2018 to USD 56.1 million in 2026. The Leishmaniasis Treatment Market is predicted to develop due to rising healthcare spending. According to the World Health Organization, “health spending is expanding faster than the rest of the world economy, accounting for 10% of global GDP.” This increasing trend in global health spending is part